Amgen-Roche Patent Brawl Over Mircera Produces Mixed Ruling At Appeals Court
Federal Circuit proves it can be as unpredictable for biologics as it often is for small molecules.
Federal Circuit proves it can be as unpredictable for biologics as it often is for small molecules.